Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Change in Accured Expenses (2014 - 2026)

Zoetis' (ZTS) quarterly Change in Accured Expenses came in at $142.0 million in Q2 2026, down 2.07% year-over-year from $145.0 million in Q2 2025, and up 160.68% quarter-over-quarter from -$234.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Change in Accured Expenses (2014 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Change in Accured Expenses for 13 consecutive years, with $142.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses fell 2.07% year-over-year to $142.0 million in Q2 2026; TTM through Jun 2026 was $54.0 million, a 61.7% decrease from a year earlier, with the FY2025 full-year figure at $85.0 million, down 25.44% from the prior year.
  • Change in Accured Expenses was $142.0 million for Q2 2026 at Zoetis, up from -$234.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $145.0 million in Q2 2025 and troughed at -$234.0 million in Q1 2026.
  • A 5-year average of -$333333.3 and a median of $34.5 million in 2023 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses plunged 208.33% in 2022 and jumped 825.0% in 2024, its largest moves.
  • Over 5 years, Change in Accured Expenses stood at $47.0 million in 2022, then soared by 100.0% to $94.0 million in 2023, then retreated by 17.02% to $78.0 million in 2024, then rose by 12.82% to $88.0 million in 2025, then soared by 61.36% to $142.0 million in 2026.
  • The last three Change in Accured Expenses figures came in at $142.0 million (Q2 2026), -$234.0 million (Q1 2026), and $88.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn -
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 142.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn -
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 28.65 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.00 Mn
Mar 31, 2026 -234.00 Mn
Dec 31, 2025 88.00 Mn
Sep 30, 2025 58.00 Mn
Jun 30, 2025 145.00 Mn
Mar 31, 2025 -206.00 Mn
Dec 31, 2024 78.00 Mn
Sep 30, 2024 124.00 Mn
Jun 30, 2024 37.00 Mn
Mar 31, 2024 -125.00 Mn
Dec 31, 2023 94.00 Mn
Sep 30, 2023 32.00 Mn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 -63.00 Mn
Dec 31, 2022 47.00 Mn
Sep 30, 2022 -21.00 Mn
Jun 30, 2022 16.00 Mn
Mar 31, 2022 -222.00 Mn
Dec 31, 2021 165.00 Mn
Sep 30, 2021 41.00 Mn